Plain-English translation of NCT04166266 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term tracking study for people who have both hepatitis B and Delta virus infections at the same time. Researchers will monitor your health regularly and collect blood samples to build a research database that helps them better understand how these two infections affect people and how different treatments work.
Having both hepatitis B and Delta infections together is particularly serious and complex, but there is limited data on how people manage this co-infection over time and how well different treatment approaches work. This study aims to fill that gap by carefully following patients and learning from their real-world experiences.
You likely qualify if…
You likely don't qualify if…
You will have regular check-ups according to your treatment status—typically every 6 months if you are not being treated, or more frequently if you are receiving specific medications. At each visit, you will have blood drawn for the research biobank and may complete questionnaires about your health. If you join optional sub-studies, there may be additional blood tests, but your regular medical care follows standard recommendations for hepatitis B and Delta co-infection.
AI-generated summary from trial data · Jul 8, 2026 · Not medical advice
France